Key facts
- Notable investors include TusStar Incubator, Fangxin Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Liheng (Hainan) Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Liheng (Hainan) Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Liheng (Hainan) Medical Technology
Manufacturer of medical devices and biomedical technologies intended for clinical research and healthcare applications. The company offers production and leasing of Class I, II, and III medical instruments, internet-based medical device services, and R&D in biomedical engineering and new materials, enabling hospitals, research institutions, and healthcare providers to access compliant, customizable, and technologically advanced solutions that support diagnostics, treatment, and innovation in regulated medical environments through localized manufacturing and angel-funded development.
- Sector
- Healthcare
- HQ
- Sanya, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Liheng (Hainan) Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Liheng (Hainan) Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Liheng (Hainan) Medical Technology in its N-PORT filings yet. We sweep new filings monthly.